NASDAQ:AKBA   Akebia Therapeutics, Inc.
I like this one for next week. This ascending channel has an established uptrend and presents an attractive risk/reward at 3.05 entry. I am looking for this to make next leg up next week to 3.30s. There was also positive news released about DoD funding and a potential FDA approval of a new drug early 2021 that may act as a driving catalyst for this in the medium term
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.